Today: 19 April 2026
Subscribe
Browse Category

NASDAQ:PSYB 19 April 2026

Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test

Psyence Biomedical in Spotlight After Trump’s Ibogaine Order Puts Supply Strategy to the Test

Psyence Biomedical shares jumped 29.5% to $7.60 after President Trump signed an order to accelerate research into psychedelic drugs, including ibogaine. The order offers faster FDA handling and $50 million in federal support but does not legalize ibogaine. Psyence, which supplies GMP-grade ibogaine, has no approved products and its lead drug is still in Phase IIb trials.
19 April 2026
·

Stock Market Today

  • Navan IPO Boosts Group 11's Fifth Fund After Years of Losses
    April 19, 2026, 12:57 PM EDT. Group 11's fifth fund, managed by Dovi Frances, has bounced back after three years of losses, driven by gains linked to the Navan IPO. The fund's assets grew from below $190 million to $252.6 million, surpassing its 2021 level despite prior write-downs amid weak tech demand. Early support for Navan, which went public at a $6 billion valuation, was a key factor. However, Navan's shares have since dropped about 25%. Group 11, a fintech-focused venture capital firm, offers this fund as one of its few open to public investors, traded on the Tel Aviv Stock Exchange's TASE UP platform. Still, overall returns lag broader markets since the fund's 2021 launch.

Latest article

Medical Properties Trust, Inc. Faces Fresh Tenant Stress as Debt Maturities Loom

Medical Properties Trust, Inc. Faces Fresh Tenant Stress as Debt Maturities Loom

19 April 2026
Medical Properties Trust closed Friday at $5.23, up 0.58%, as several hospitals tied to its new tenant base showed fresh signs of financial strain. The company faces $1.23 billion in debt maturing in 2026 and $1.6 billion in 2027. MPT says new operators are current on rent and still targets $1 billion in annualized cash rent by the end of 2026. Shareholders will meet May 28 in Birmingham.
Why Rolls-Royce Holdings Is Back in Focus: UK Nuclear Deal, Dividend Date and Fresh Share Momentum

Why Rolls-Royce Holdings Is Back in Focus: UK Nuclear Deal, Dividend Date and Fresh Share Momentum

19 April 2026
Rolls-Royce shares jumped 4.8% Friday as UK defence stocks rallied, lifting the FTSE 100. The company goes ex-dividend April 23 and holds its AGM April 30 after announcing a £7–9 billion buyback and a 5 pence final 2025 dividend. Britain signed a contract with Rolls-Royce SMR to begin design work on the first UK small modular reactors. Rolls-Royce also reported German test benches now run on HVO fuel.
Go toTop